Histopathologic changes following neoadjuvant chemotherapy in various malignancies

Area of Science:

• Oncology
• Pathology
• Chemotherapy Research

Background:

• Histopathological changes after neoadjuvant chemotherapy are documented in various tumors.
• Breast cancer serves as a primary model for observing these changes.

Purpose of the Study:

• To document histopathologic alterations in breast malignancies and other cancers post-neoadjuvant chemotherapy.
• To utilize breast cancer as a predominant model for this investigation.

Main Methods:

• A prospective study involving 60 patients (40 breast cancer, 20 other malignancies) who received neoadjuvant chemotherapy.
• Analysis of mastectomy specimens to identify histopathological changes.

Main Results:

• Observed changes include nuclear/cytoplasmic vacuolation, shrinkage, necrosis, and nonviability markers (karyorrhexis, karyolysis, pyknosis).
• Stromal reactions included fibrosis, elastosis, collagenization, hyalinization, microcalcification, and neovascularization.
• Lymphocytic infiltration was the most common inflammatory response, with giant cell reaction correlating significantly with tumor response.

Conclusions:

• Neoadjuvant chemotherapy leads to retrogressive changes and increased stromal components in breast and other malignancies.
• Chemotherapy results in decreased tumor grade and improved differentiation.
• Histopathological evaluation is crucial for assessing treatment response.